KRAS and lung carcinoma: In a lung cancer mouse model, it has been demonstrated that IL-10 and TGFβ secreted by KRAS mutated cancer cells, induce the conversion of CD4+ CD25- T-cells into FOXP3+/CTLA4+/CD122+ T regulatory cells (Tregs) (117).